Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender Patients with age 18 to 70 years Serum uric acid level >7 mg / dl for men and > 6 mg / dl for women Chronic cases of gout ( more than 1 year )
Exclusion criteria
Exclusion criteria: Immunocompromised patients or patients on immunosuppressive drugs Patients suffering from life threatening diseases Pregnant women and lactating mother Patients with k/c/o hypersensitivity of any drug Patients suffering from chronic kidney diseases or end stage renal diseases and requiring dialysis Patients taking diuretics, aspirin, ethambutol, pyrazinamide, cyclosporine, cytotoxic drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patoladi kwatha more effective in management of vaatarakta than febuxostatTimepoint: once in a month for three months | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of patoladi kwatha will be less effective as compared to febuxostat on vaataraktaTimepoint: once in a month for three months | — |
Countries
India
Contacts
Y.M.T. Ayurvedic medical college